The "Invitation&quo☆γ¶t; on March 14-15, 2024, Haibu Pharmace↔α★←utical invites you to g♥δ☆ather in Hangzhou for th∏€e [National Pharmaceutical R&✘πD and Investment Merger an☆↑♣d Acquisition Cooperation Conference]₩€.

Beijing Haibu Pharmace$§utical Technology Co., Ltd.  ∞(referred to as "Haibu Phar↔π €maceutical") was established in 2005 a←☆nd is a high-tech enterprise with ±≥"chemical drug researασch and development" as its core cσ÷apability. It has a research and d≤≥evelopment center in Be&δ✔ijing, a pilot verification centeδ §r for raw materials and formulations, a↕★nd a GMP industrial productio£€n base, mainly engaged in CRO ser ∏vices for raw materi±←als and formulations, MAH jointγ♠"¥ licensing, related appli§±>cations for raw materials, and comme"≥rcial supply of pharmaceutical in♠‌termediates.It has rich experienceε≥©₹ in the research and production $←transfer, registration applic$​™←ation, etc., of vari'→ous dosage forms such as chemical rawε< materials, oral solids,​↑γ liquid preparations, sterile i'εnjections, and external preparations.π   The R&D products cover multipleβ"¥∞ therapeutic areas including anti-tumo≥πr, anti-depression, anti-epilepsy, ant↑♦Ω↔i-anxiety, cardiovascular and cer♦δebrovascular diseases, di®♦≠gestive system disorders, respirat₽ ory system issues, etc.

Haibu Pharmaceutical has been award₹σed the title of "Top 20 Pharm✘λ↔aceutical R&D Compan¶♦ies in China" for several conπ☆‌ secutive years and ha¥πs been recognized as a "Speci‍∑β∏alized and Innovative" enterpris≤✔e in Beijing, a "Natio→∞σ≥nal High-tech Enterprise", a ✘×ε↔"Beijing Science and T↓‌↔echnology Research Development Insti ®tution", and a "Beijing ≤★☆Yizhuang Enterprise Inn• >♦ovation Center", among others.